Found 86 results
Author Title Type [ Year(Asc)]
Filters: First Letter Of Title is T  [Clear All Filters]
J. Bolaños-Meade, Reshef, R., Fraser, R., Fei, M., Abhyankar, S., Al-Kadhimi, Z., Alousi, A. M., Antin, J. H., Arai, S., Bickett, K., Bin Chen, Y. -, Damon, L. E., Efebera, Y. A., Geller, N. L., Giralt, S. A., Hari, P., Holtan, S. G., Horowitz, M. M., Jacobsohn, D. A., Jones, R. J., Liesveld, J. L., Logan, B. R., MacMillan, M. L., Mielcarek, M., Noel, P., Pidala, J., Porter, D. L., Pusic, I., Sobecks, R., Solomon, S. R., Weisdorf, D. J., Wu, J., Pasquini, M. C., and Koreth, J., Three prophylaxis regimens (tacrolimus, mycophenolate mofetil, and cyclophosphamide; tacrolimus, methotrexate, and bortezomib; or tacrolimus, methotrexate, and maraviroc) versus tacrolimus and methotrexate for prevention of graft-versus-host disease with, Lancet Haematol, vol. 6, no. 3, pp. e132-e143, 2019.
K. M. Keppler-Noreuil, Lozier, J., Oden, N., Taneja, A., Burton-Akright, J., Sapp, J. C., and Biesecker, L. G., Thrombosis risk factors in PIK3CA-related overgrowth spectrum and Proteus syndrome., Am J Med Genet C Semin Med Genet, vol. 181, no. 4, pp. 571-581, 2019.
C. S Johnston, Elm, J. J., J Easton, D., Farrant, M., Barsan, W. G., Kim, A. S., Lindblad, A. S., Palesch, Y. Y., Zurita, K. G., Albers, G. W., Cucchiara, B. L., Kleindorfer, D. O., Lutsep, H. L., Pearson, C., Sethi, P., and Vora, N., Time Course for Benefit and Risk of Clopidogrel and Aspirin After Acute Transient Ischemic Attack and Minor Ischemic Stroke., Circulation, vol. 140, no. 8, pp. 658-664, 2019.
A. F. Holtyn, Bosworth, E., Marsch, L. A., McLeman, B., Meier, A., Saunders, E. C., Ertin, E., Ullah, M. Azim, Samiei, S. Alan, Hossain, M., Kumar, S., Preston, K. L., Vahabzadeh, M., Shmueli-Blumberg, D., Collins, J., McCormack, J., and Ghitza, U. E., Towards detecting cocaine use using smartwatches in the NIDA clinical trials network: Design, rationale, and methodology., Contemp Clin Trials Commun, vol. 15, p. 100392, 2019.
E. V. Maarseveen, Rogers, C., Trofe-Clark, J., Lghoul, F., Wong, M., Zuilen, A. V., Mudrikova, T., Barin, B., Stock, P., and Frassetto, L., Tacrolimus Exposure and its Relation with Clinical Outcomes in HIV Infected Kidney Transplant Recipients on Antiretroviral Agents: An Area-Under-The-Curve Driven Analysis, in World Transplant Congress, San Francisco, CA, 2014.
C. Cutler, Logan, B., Nakamura, R., Johnston, L., Choi, S., Porter, D., Hogan, W. J., Pasquini, M., MacMillan, M. L., Hsu, J. W., Waller, E. K., Grupp, S., McCarthy, P., Wu, J., Hu, Z. - H., Carter, S. L., Horowitz, M. M., and Antin, J. H., Tacrolimus/sirolimus vs tacrolimus/methotrexate as GVHD prophylaxis after matched, related donor allogeneic HCT., Blood, vol. 124, no. 8, pp. 1372-7, 2014.
C. Cutler, Logan, B., Nakamura, R., Johnston, L., Choi, S., Porter, D., Hogan, W. J., Pasquini, M., MacMillan, M. L., Hsu, J. W., Waller, E. K., Grupp, S., McCarthy, P., Wu, J., Hu, Z. H., Carter, S. L., Horowitz, M. M., and Antin, J. H., Tacrolimus/Sirolimus vs Tacrolimus/Methotrexate as GVHD Prophylaxis After Matched, Related Donor Allogeneic HCT, Blood, vol. 124, pp. 1372-1377, 2014.
N. Oden and Sharma, G., Tangency Outcomes for Clinical Trials, in Society for Clinical Trials 35th Annual Meeting, Philadelphia, PA, 2014.
E. Y. Chew, Clemons, T. E., Agrón, E., Sperduto, R. D., Sangiovanni, J. Paul, Davis, M. D., and Ferris, F. L., Ten-year follow-up of age-related macular degeneration in the age-related eye disease study: AREDS report no. 36., JAMA Ophthalmol, vol. 132, no. 3, pp. 272-7, 2014.
E. Y. Chew, Clemons, T. E., Agron, E., Sperduto, R. D., SanGiovanni, J. P., Davis, M. D., 3rd, F. L. Ferris, and AREDS), T. Age- Relate, Ten-Year Follow-up of Age-Related Macular Degeneration in the Age-Related Eye Disease Study: AREDS Report No. 36, JAMA Ophthalmol, vol. 132, pp. 272-277, 2014.
G. Sharma, Van Veldhuisen, P., and Allen, C. A., Tracking and Monitoring Trial Progress in NIDA CTN Studies, in NIH Workshop on Enrollment and Retention of Participants in NIH-funded Clinical Trials, Bethesda, MD, 2014.
A. W. Heldman, DiFede, D. L., Fishman, J. E., Zambrano, J. P., Trachtenberg, B. H., Karantalis, V., Mushtaq, M., Williams, A. R., Suncion, V. Y., McNiece, I. K., Ghersin, E., Soto, V., ,, Da Silva, J., Anderson, E., Schwarz, R., Mendizabal, A., and Hare, J. M., Transendocardial Mesenchymal Stem Cells and Mononuclear Bone Marrow Cells for Ischemic Cardiomyopathy: The TAC-HFT Randomized Trial, JAMA, vol. 311, pp. 62-73, 2014.
E. Atallah, Bylow, K., Troy, J., and W, S., Treatment of Older Patients with High-Risk Myelodysplastic Syndromes (MDS): the Emerging Role of Allogeneic Hematopoietic Stem Cell Transplantation (Allo HSCT), Curr Hematol Malig Rep, vol. 9, pp. 57-65, 2014.
E. Atallah, Bylow, K., Troy, J., and Saber, W., Treatment of older patients with high-risk myelodysplastic syndromes (MDS): the emerging role of allogeneic hematopoietic stem cell transplantation (Allo HSCT)., Curr Hematol Malig Rep, vol. 9, no. 1, pp. 57-65, 2014.